Back to Screener

Consumer Defensive

Reckitt Benckiser Group plc(RBGLY)

Live Price

Offline

$12.43

+0.81% today

1Y Change

-13.53%

Window

Jun 23, 2025 โ†’ Jun 18, 2026

Market Cap
$30.20B
Revenue Growth
-1.9%
EPS Growth
+134.8%
Dividend Yield
9.8%

Coverage: 249 bars ยท Jun 23, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Reckitt Benckiser Group plc (RBGLY) is a Consumer Defensive stock with a market cap of $30.20B and listed on OTC. The stock last traded around $12.43 and down 13.5% across the available one-year price window (Jun 23, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of -1.9%, EPS growth of +134.8%, a dividend yield of 9.8%. What stands out right now is revenue -1.9%, EPS +134.8%, free cash flow -22.3% with operating margin 32.4% and ROIC 15.4%. The dividend matters to the case here, with a current yield around 9.8%. Valuation is more restrained than many high-expectation growth names at P/E 11.3 and price/sales 2.8. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines RBGLY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-1.9% vs +1.7% peer median

Operating Margin

Above sector median

+32.4% vs +6.6% peer median

P/E

Below sector median

11.3 vs 14.0 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report was closer to in-line

2026 was reported on Mar 5, 2026 with revenue ahead of estimates by 0.0%.

The operating picture looks softer than before

Revenue is at -1.9% and EPS is at +134.8%, with operating margin around 32.4%.

The next real check-in already has a date

The next earnings event is scheduled for Jul 29, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -2.6% over the next 5 trading days and finished higher after 1 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
Mar 5, 2026
+0.0%-2.0%-8.2%-10.3%
2025
Jun 30, 2025
-13.9%+0.9%+0.9%+10.6%
2024
Dec 31, 2024
-74.1%+0.4%-0.5%-0.2%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

RBGLY

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

RBGLY Max Drawdown

-31.78%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for RBGLY and SPY.

Calendar-year return history is still loading or unavailable.
Reckitt Benckiser Group plc logo

Company Overview

Reckitt Benckiser Group plc

Other OTC

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Leadership
Kristoffer Loe Licht
IPO Date
Oct 15, 2008
Employees
37.9k
Street Address
Turner House
Mailing
Slough, SL1 3UH
Region
Slough, GB
Reporting Currency
USD
Investor Line
44 17 5321 7800
Last Updated
May 4, 2026
CIK: 0001420798ISIN: US7562553039CUSIP: 756255204
ADR ListedReports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
11.3
EV/EBITDA
10.2
Price/Sales
2.8
Price/Book
3.9

Growth

Revenue
-1.9%
EPS
+134.8%
Free Cash Flow
-22.3%

Profitability

Gross Margin
60.7%
Operating Margin
32.4%
Net Margin
25.2%
ROE
38.5%
ROIC
15.4%

Balance Sheet

Debt/Equity
1.09
Current Ratio
0.85

Earnings Reports

๐Ÿ“… Next earningsJul 29, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Jul 29, 26
TBD
โ€”
Est 0.44
โ€”
โ€”
Est 8348620.0B
โ€”
โ€”
Mar 5, 26
โ€”
0.50
Est 0.50
0.0%
9899807.0B
Est 9899806.0B
0.0%
โ€”
Jun 30, 25
โœ—
0.38
Est 0.44
-13.9%
9513148.3B
Est 9560189.5B
-0.5%
โ€”
Dec 31, 24
โœ—
0.10
Est 0.39
-74.1%
8760412.3B
Est 9104758.8B
-3.8%
โ€”
Jun 30, 24
โœ“
0.41
Est 0.39
+3.3%
9071271.9B
Est 9104847.0B
-0.4%
โ€”
Dec 31, 23
โœ—
0.14
Est 0.37
-61.6%
9051514.2B
Est 8996990.7B
+0.6%
โ€”
Jun 30, 23
โœ“
0.43
Est 0.43
+0.7%
9429055.9B
Est 9278300.0B
+1.6%
โ€”
Dec 31, 22
โœ—
0.34
Est 0.41
-17.4%
9297914.6B
Est 9347614.5B
-0.5%
โ€”
Jul 27, 22
โœ“
0.46
Est 0.36
+26.8%
8361120.5B
Est 8122170.3B
+2.9%
โ€”
Apr 29, 22
โœ“
0.64
Est 0.40
+59.5%
8951442.4B
Est 8966725.0B
-0.2%
โ€”
Oct 26, 21
โœ—
-0.67
Est 0.39
-269.5%
9116764.5B
Est 9325949.9B
-2.2%
โ€”
Dec 31, 20
โœ—
0.04
Est 0.44
-90.4%
9633265.7B
Est 9778748.8B
-1.5%
โ€”
Oct 20, 20
โœ—
0.38
Est 0.43
-13.4%
8613570.9B
Est 8578039.5B
+0.4%
โ€”
Apr 30, 20
โœ—
-1.37
Est 0.48
-382.8%
8467376.4B
Est 8591374.4B
-1.4%
โ€”
Jul 30, 19
0.04
Est โ€”
โ€”
7908729.9B
Est โ€”
โ€”
โ€”
May 2, 19
0.49
Est โ€”
โ€”
8675827.5B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.